Baghdad – INA
Iraqi scientist Associate Professor Dr. Adel Abdulrahman Sadiq al-Salhi has published a new scientific study in a reputable international journal specializing in neuroimmunology, issued by Elsevier, presenting a modern immune-based classification of autism spectrum disorder.
Al-Salhi told the Iraqi News Agency (INA) that the research does not treat autism as a single, uniform condition among all children, but rather opens the door to understanding it as a diverse biological spectrum, with some patterns having clear and measurable immune-related roots.
He added that the new classification includes six main immune patterns and could form a future basis for shifting from general behavioral diagnosis to precise biological diagnosis, helping to develop more tailored therapeutic interventions.
Al-Salhi explained that the importance of the study lies in shifting the scientific question from “What is autism?” to “Which biological subtype of autism are we dealing with?”, noting that this could pave the way for a new phase based on precision medicine, biomarkers, and targeted therapies.
The publication follows a previous announcement that al-Salhi had registered a patent in the United States for an innovative experimental treatment for autism, as part of an Iraqi research track aimed at understanding the biological causes of autism and opening new therapeutic horizons.
Al-Salhi emphasized that this classification presents a new scientific framework for understanding a significant group of children who may have immune or inflammatory disorders linked to the autism pathway.